Alpha 2.0
Login Register
» Authors » Amal Muthumala

Amal Muthumala

Explore the profile of Amal Muthumala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 37
Citations 262
Followers 0
Related Specialties
Cardiology & Vascular Diseases
Physiology
Science
Top 10 Co-Authors
Simon Sporton
Pier D Lambiase
Ross J Hunter
Darrel P Francis
Daniel Keene
Christopher Monkhouse
Philip Moore
Richard J Schilling
Prapa Kanagaratnam
Antonio Creta
Published In
Pacing Clin Electrophysiol
Europace
Eur J Heart Fail
Sci Rep
JACC Clin Electrophysiol
Affiliations
Soon will be listed here.
Recent Articles
1.
Emergency pacemaker implantation in nonagenarians with CHB: single-versus dual-chamber pacing
Mahtani K, MacLean E, Parker M, Vyas R, Wang R, Roelas M, et al.
Br J Cardiol . 2024 Nov; 31(2):024. PMID: 39555470
In ambulatory patients with complete heart block (CHB), dual-chamber (DDD) pacing confers physiological benefits versus single-chamber (VVI) pacing, however, the impact on mortality is disputed. Nonagenarians constitute an expanding proportion...
2.
Implantable Cardiac Devices in Patients with Brady- and Tachy-Arrhythmias: An Update of the Literature
Chick W, Monkhouse C, Muthumala A, Ahsan S, Papageorgiou N
Rev Cardiovasc Med . 2024 Jul; 25(5):162. PMID: 39076493
Implantable cardiac devices are a vital treatment option in the management of tachy/brady-arrhythmias and heart failure with conduction disease. In the recent years, these devices have become increasingly sophisticated, with...
3.
Predictors of the efficacy of His bundle pacing in patients with a prolonged PR interval: A stratified analysis of the HOPE-HF randomized controlled trial
Keene D, Kaza N, Srinivasan D, Ali N, Tanner M, Foley P, et al.
Eur J Heart Fail . 2024 Jul; 26(10):2261-2268. PMID: 39023285
Aims: The randomized, double-blind, placebo-controlled HOPE-HF trial assessed the benefit of atrio-ventricular (AV) delay optimization delivered using His bundle pacing. It recruited patients with left ventricular ejection fraction ≤40%, PR...
4.
Blood groups and Rhesus status as potential predictors of outcomes in patients with cardiac resynchronisation therapy
Papageorgiou N, Sohrabi C, Bakogiannis C, Tsarouchas A, Kukendrarajah K, Matiti L, et al.
Sci Rep . 2024 Apr; 14(1):8371. PMID: 38600217
Cardiac resynchronisation therapy (CRT) improves prognosis in patients with heart failure (HF) however the role of ABO blood groups and Rhesus factor are poorly understood. We hypothesise that blood groups...
5.
The BLISTER Score: A Novel, Externally Validated Tool for Predicting Cardiac Implantable Electronic Device Infections, and Its Cost-Utility Implications for Antimicrobial Envelope Use
MacLean E, Mahtani K, Honarbakhsh S, Butcher C, Ahluwalia N, Dennis A, et al.
Circ Arrhythm Electrophysiol . 2024 Jan; 17(3):e012446. PMID: 38258308
Background: Antimicrobial envelopes reduce the incidence of cardiac implantable electronic device infections, but their cost restricts routine use in the United Kingdom. Risk scoring could help to identify which patients...
6.
Detecting deceased patients on cardiac device remote monitoring: A case series and management guide for cardiac device services
Monkhouse C, Elliott J, Whittaker-Axon S, Collinson J, Chow A, Moore P, et al.
Heart Rhythm . 2023 Dec; 21(3):303-312. PMID: 38048935
Background: Remote monitoring (RM) of implantable cardiac devices provides substantial and complex information, presenting new challenges such as detection of a patient's death. Objective: This study aims to describe RM...
7.
DOACs vs Vitamin K Antagonists During Cardiac Rhythm Device Surgery: A Multicenter Propensity-Matched Study
Creta A, Ventrella N, Earley M, Finlay M, Sporton S, MacLean E, et al.
JACC Clin Electrophysiol . 2023 Oct; 10(1):121-132. PMID: 37897463
Background: There is a paucity of data comparing vitamin K antagonists (VKAs) to direct oral anticoagulants (DOACs) at the time of cardiac implantable electronic device (CIED) surgery. Furthermore, the best...
8.
Left bundle branch pacing with and without anodal capture: impact on ventricular activation pattern and acute haemodynamics
Ali N, Saqi K, Arnold A, Miyazawa A, Keene D, Chow J, et al.
Europace . 2023 Oct; 25(10). PMID: 37815462
Aims: Left bundle branch pacing (LBBP) can deliver physiological left ventricular activation, but typically at the cost of delayed right ventricular (RV) activation. Right ventricular activation can be advanced through...
9.
Septal scar as a barrier to left bundle branch area pacing
Ali N, Arnold A, Miyazawa A, Keene D, Peters N, Kanagaratnam P, et al.
Pacing Clin Electrophysiol . 2023 Aug; 46(9):1077-1084. PMID: 37594233
Background: The use of left bundle branch area pacing (LBBAP) for bradycardia pacing and cardiac resynchronization is increasing, but implants are not always successful. We prospectively studied consecutive patients to...
10.
Comparison of methods for delivering cardiac resynchronization therapy: an acute electrical and haemodynamic within-patient comparison of left bundle branch area, His bundle, and biventricular pacing
Ali N, Arnold A, Miyazawa A, Keene D, Chow J, Little I, et al.
Europace . 2023 Feb; 25(3):1060-1067. PMID: 36734205
Aims: Left bundle branch area pacing (LBBAP) is a promising method for delivering cardiac resynchronization therapy (CRT), but its relative physiological effectiveness compared with His bundle pacing (HBP) is unknown....